|
🦁
|
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.
10 auth.
P. Collins,
S. Hirsch,
T. Baglin,
G. Dolan,
J. Hanley,
M. Makris,
...
D. Keeling,
R. Liesner,
S. Brown,
C. Hay
|
9 |
2007 |
9
🦁
|
|
🐜
|
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
9 auth.
A. Huth‐Kühne,
F. Baudo,
P. Collins,
J. Ingerslev,
C. Kessler,
H. Lévesque,
...
M. E. M. Castellano,
M. Shima,
J. St-Louis
|
8 |
2009 |
8
🐜
|
|
🐢
|
Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients
Pratima Chowdhury,
A. Saayman,
U. Paulus,
G. Findlay,
P. Collins
|
8 |
2004 |
8
🐢
|
|
🐜
|
A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO
13 auth.
P. Bolton-Maggs,
E. Chalmers,
P. Collins,
P. Harrison,
S. Kitchen,
R. Liesner,
A. Minford,
A. Mumford,
L. Parapia,
D. Perry,
...
S. Watson,
J. Wilde,
Michael D. Williams
|
8 |
2006 |
8
🐜
|
|
🐜
|
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.
9 auth.
F. Baudo,
P. Collins,
A. Huth‐Kühne,
H. Lévesque,
P. Marco,
L. Nemes,
...
F. Pellegrini,
L. Tengborn,
P. Knoebl
|
8 |
2012 |
8
🐜
|
|
🦁
|
Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
10 auth.
P. Collins,
V. Blanchette,
K. Fischer,
S. Björkman,
Myungshin Oh,
S. Fritsch,
...
P. Schroth,
G. Spotts,
J. Astermark,
B. Ewenstein
|
8 |
2009 |
8
🦁
|
|
🐜
|
Acquired hemophilia A: Updated review of evidence and treatment guidance
8 auth.
R. Kruse-Jarres,
C. Kempton,
F. Baudo,
P. Collins,
P. Knoebl,
C. Leissinger,
...
A. Tiede,
C. Kessler
|
8 |
2017 |
8
🐜
|
|
🦁
|
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
9 auth.
P. Collins,
F. Baudo,
P. Knoebl,
H. Lévesque,
L. Nemes,
F. Pellegrini,
...
P. Marco,
L. Tengborn,
A. Huth‐Kühne
|
8 |
2012 |
8
🦁
|
|
🐜
|
International recommendations on the diagnosis and treatment of acquired hemophilia A
12 auth.
A. Tiede,
P. Collins,
P. Knoebl,
J. Teitel,
C. Kessler,
M. Shima,
...
G. Di Minno,
R. d’Oiron,
P. Salaj,
V. Jiménez‐Yuste,
A. Huth‐Kühne,
P. Giangrande
|
7 |
2020 |
7
🐜
|
|
🦁
|
Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study.
16 auth.
P. Collins,
G. Lilley,
D. Bruynseels,
D. B. Laurent,
R. Cannings-John,
E. Precious,
V. Hamlyn,
J. Sanders,
R. Alikhan,
R. Rayment,
...
A. Rees,
A. Kaye,
J. Hall,
S. Paranjothy,
A. Weeks,
R. Collis
|
7 |
2014 |
7
🦁
|
|
🦁
|
Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens
10 auth.
P. Collins,
S. Björkman,
K. Fischer,
V. Blanchette,
Myungshin Oh,
P. Schroth,
...
S. Fritsch,
K. Casey,
G. Spotts,
B. Ewenstein
|
7 |
2010 |
7
🦁
|
|
🐢
|
Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.
10 auth.
S. Björkman,
Myungshin Oh,
G. Spotts,
P. Schroth,
S. Fritsch,
B. Ewenstein,
...
K. Casey,
K. Fischer,
V. Blanchette,
P. Collins
|
7 |
2012 |
7
🐢
|
